| Applying non-animal strategies for assessing skin sensitisation report from an EPAA/cefic-LRI/IFRA Europe cross sector workshop, ECHA helsinki, February 7th and 8th 2019 | Regulatory toxicology and pharmacology | 9 days | save |  |  |  |  |
| Evaluation of preclinical safety profile of SPH3127, a direct renin inhibitor, after 28-day repeated oral administration in Sprague-Dawley rats and cynomolgus monkeys | Regulatory toxicology and pharmacology | 9 days | save | | | | |
| Subchronic toxicity evaluation of ethanol extract of Cassia tora L. seeds in rats | Regulatory toxicology and pharmacology | 12 days | save | | | | |
| Quantitative prediction of repeat dose toxicity values using GenRA | Regulatory toxicology and pharmacology | 20 days | save | | | | |
| Comparative levels of carbonyl delivery between mass-market cigars and cigarettes | Regulatory toxicology and pharmacology | 20 days | save | | | | |
| Dermal absorption study OECD TG 428 mass balance recommendations based on the EFSA database | Regulatory toxicology and pharmacology | 20 days | save | | | | |
| In vitro RHE skin sensitisation assays: Applicability to challenging substances | Regulatory toxicology and pharmacology | 20 days | save | | | | |
| Time to first cigarette of the day and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in adult regular and non-daily smokers: (NHANES) 2007–10 | Regulatory toxicology and pharmacology | 20 days | save | | | | |
| Derivation of a chronic reference dose for perfluorohexane sulfonate (PFHxS) for reproductive toxicity in mice | Regulatory toxicology and pharmacology | 21 days | save | | | | |
| The ADME profile of the fungicide tricyclazole in rodent via the oral route: A critical review for human health safety assessment | Regulatory toxicology and pharmacology | 27 days | save | | | | |
| Consumer safety evaluation of pyraclostrobin residues in strawberry using liquid chromatography tandem mass spectrometry (LC-MS/MS): An Egyptian profile | Regulatory toxicology and pharmacology | 34 days | save | | | | |
| Investigation of quality review issues and the association with application characteristics for new drug applications in first-cycle reviews | Regulatory toxicology and pharmacology | 37 days | save | | | | |
| Characterization of in vitro Mrp2 transporter model based on intestinal organoids | Regulatory toxicology and pharmacology | 40 days | save | | | | |
| Dissipation rates and residue levels of diflubenzuron and difenoconazole on peaches and dietary risk assessment | Regulatory toxicology and pharmacology | 43 days | save | | | | |
| Data derived Extrapolation Factors for developmental toxicity: A preliminary research case study with perfluorooctanoate (PFOA) | Regulatory toxicology and pharmacology | 48 days | save | | | | |
| Reproductive and developmental toxicity screening of polyhexamethylene guanidine phosphate by oral gavage in rats | Regulatory toxicology and pharmacology | 49 days | save | | | | |
| Metabolomics as read-across tool: An example with 3-aminopropanol and 2-aminoethanol | Regulatory toxicology and pharmacology | 49 days | save | | | | |
| Control performance of fish short term reproduction assays with fathead minnow (Pimephales promelas) | Regulatory toxicology and pharmacology | 63 days | save | | | | |
| Elemental impurities in pharmaceutical products adding fuel to the fire | Regulatory toxicology and pharmacology | 63 days | save | | | | |
| Nonclinical safety assessment of PF614: A novel TAAP prodrug of oxycodone for chronic pain indication | Regulatory toxicology and pharmacology | 63 days | save | | | | |
| Comparative pharmacokinetic and biodistribution study of two distinct squalene-containing oil-in-water emulsion adjuvants in H5N1 influenza vaccines | Regulatory toxicology and pharmacology | 63 days | save | | | | |
| Scientific assessments in European food law: Making it future-proof | Regulatory toxicology and pharmacology | 72 days | save | | | | |
| Towards quantitative read across: Prediction of Ames mutagenicity in a large database | Regulatory toxicology and pharmacology | 77 days | save | | | | |
| Determination of offspring NOAEL for zeta-cypermethrin using internal exposure data from rat developmental neurotoxicity studies | Regulatory toxicology and pharmacology | 81 days | save | | | | |
| Toxicology and human health risk assessment of polyethoxylated tallow amine surfactant used in glyphosate formulations | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Investigation of number of replicate measurements required to meet cigarette smoke chemistry regulatory requirements measured under Canadian intense smoking conditions | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Proposal of GHS sub-categorization criteria for LLNA: BrdU-ELISA (OECD TG442B) | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Exposure assessments in reproductive and developmental toxicity testing: An IQ-DruSafe industry survey on current practices and experiences in support of exposure-based high dose selection | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Mechanistic relationship between biodegradation and bioaccumulation. Practical outcomes | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Testing developmental toxicity in a second species: are the differences due to species or replication error? | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Distribution of fluoride contamination in drinking water resources and health risk assessment using geographic information system, northwest Iran | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Biosafety of unmodified ultrafine gold particles (AuPs) upon interacting with human blood components before systemic use | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Comparative study of feminine hygiene product regulations in Korea, the European Union, and the United States | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Evaluation of skin sensitization potential of chemicals by local lymph node assay using 5-bromo-2-deoxyuridine with flow cytometry | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Assessment of hypolipidemic, anti-inflammatory and antioxidant properties of medicinal plant Erica multiflora in triton WR-1339-induced hyperlipidemia and liver function repair in rats: A comparison with fenofibrate | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| In vitro and in vivo genotoxicity studies on monosodium L-glutamate monohydrate | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Garlic and allopurinol attenuate hepatic apoptosis induced by fipronil in male albino rats | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Curation and analysis of clinical pathology parameters and histopathologic findings from eTOXsys, a large database project (eTOX) for toxicologic studies | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Opinion of the Scientific Committee on consumer safety (SCCS) – Final opinion on the safety of fragrance ingredient Acetylated Vetiver Oil (AVO) - (Vetiveria zizanioides root extract acetylated) - Submission III | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Opinion of the Scientific Committee on Consumer safety (SCCS) – Opinion on Ethylzingerone - ‘Hydroxyethoxyphenyl Butanone’ (HEPB) - Cosmetics Europe No P98 - CAS No 569646-79-3 - Submission II (eye irritation) | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Genetic toxicology in silico protocol | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Considerations for refining the risk assessment process for formaldehyde: Results from an interdisciplinary workshop | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Bridging communities in the field of nanomedicine | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Non-relevance of acute dermal toxicity testing for assessing human health protection in the regulatory decision-making for agrochemical formulated products | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| The impact on classifications for carcinogenicity, mutagenicity, reproductive and specific target organ toxicity after repeated exposure in the first ten years of the REACH regulation | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Predicting estrogen receptor activation by a group of substituted phenols: An integrated approach to testing and assessment case study | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Derivation of biomonitoring equivalents (BE values) for zinc | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Innovative selection approach for a new antifungal agent mefentrifluconazole (Revysol®) and the impact upon its toxicity profile | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| Assessing in vitro dermal absorption of dry residues of agrochemical sprays using human skin within OECD TG 428 | Regulatory toxicology and pharmacology | 113 days | save | | | | |
| | 
report | next » |
| |
